About 400 results
Open links in new tab
Investors | Surrozen
Surrozen Announces Strategic Partnership with Boehringer …
Surrozen to Present at Upcoming Healthcare Investor Conferences
Surrozen Debuts as Publicly Traded Leader in Wnt Biology and …
Surrozen Initiates Dosing in Phase 1 Clinical Trial of SZN-043 for ...
Surrozen and TCGFB, Inc. Announce Strategic Research …
Surrozen Presents Data Demonstrating the Promise of Antibody …
News Releases | Surrozen
Surrozen Presents Data Supporting Potential of SZN-043 at The …
Stifel 2024 Healthcare Conference | Surrozen
- Some results have been removed